Trading Members of the Exchange are hereby informed that effective from Friday, December 18, 2020, the equity shares of Ravinder Heights Limited shall be listed and admitted to dealings on the Exchange in the list of T Group of Securities. Further in terms of SEBI circular No. CIR/MRD/DP/02/2012 dated January 20, 2012; the scrip will be in Trade-for-Trade segment for 10 trading days.

Members are requested to note that the above security will be a part of special pre-open session for IPO and Other category of scrip’s as per SEBI circular no. CIR/MRD/DP/01/2012 & CIR/MRD/DP/02/2012 dated January 20, 2012.

For further information on SPOS, the trading members are requested to refer to the Exchange’s notice no. 20120216-29 on Enabling Special Pre-open Session for IPO’s & Relisted Scrips. For any clarification on SPOS, the trading members may please contact the Helpdesk on 022-6136 3100 / 6136 3171.

         1.   The brief particulars of the Scheme of Arrangement are as mentioned below:

a)   The Scheme of Arrangement of the Company was approved by the Hon'ble National Company Law Tribunal (NCLT) at Chandigarh Bench vide its Order dated 09.09.2020.

b)    Appointed Date: 01.04.2019

c)    Effective date:  10.09.2020

d)    Date of Allotment:  06.10.2020

e)  Pursuant to the Scheme of Arrangement between Panacea Biotec Limited and Ravinder Heights Limited and their respective Shareholders and Creditors as sanctioned by the Chandigarh Bench of the Hon’ble National Company Law Tribunal; whereby upon coming into effect of the scheme and in consideration of the transfer and vesting of the real estate business undertaking  from Panacea Biotec Limited into Ravinder Heights Limited. Ravinder Heights Limited shall issue and allot “1(One) fully paid up equity share of Re.1/- each of Ravinder Heights Limited for every 1(One) fully paid up equity shares of Re. 1/- each held in Panacea Biotec Limited on the Record date.”

Prior to the Scheme, the paid-up Equity Capital of Ravinder Heights Limited was Rs. 1,00,000 consisting of 1,00,000 equity shares of face value of Re.1/- each and the same shall stand cancelled upon the scheme coming effect.

The issued, subscribed and paid-up Equity Capital of Ravinder Heights Limited post arrangement is Rs. 6,12,50,746 /- consisting of 6,12,50,746 equity shares of face Value of Re. 1/- each fully paid.

2.  As per Exchange Notice No. 20200917-40 dated 17.09.2020, Panacea Biotec Limited had fixed Record date as 22.09.2020 for giving effect to the Scheme of Arrangement.

3. The Information Memorandum containing all the information about the company can be viewed at https://www.bseindia.com/corporates/soa.aspx

4. The name and address of the registrar and share transfer agent of the company is as mentioned below:

Skyline Financial Services Private Limited

D-153/A, First Floor, Okhla Industrial Area, Phase-1

New Delhi-110020

Tel: +91 - 11- 40450193

Fax: +91 - 11- 26812682

E-mail: info@skylinerta.com

Website: www.skylinerta.com

Contact person: Mr. Dinesh Kumar

5. The shareholding pattern of the company post scheme of arrangement is enclosed as Annexure-I.

Nitinkumar Pujari

Senior Manager